Journal Home
Search for

Articles in Press

Return to articles in press list

Characterization of a novel transgenic rat carrying human tau with mutation P301L

P. KorhonenaCorresponding Author Informationemail address, T. van Groenb, A. Thornella, S. Kyrylenkoc, M.-L. Soininena, J. Ojalaa, E. Peltomaaa, H. Tanilad, A. Salminena, E.M. Mandelkowe, H. Soininenf

Received 1 July 2009; received in revised form 14 December 2009; accepted 24 December 2009. published online 25 January 2010.
Corrected Proof

Abstract 

We have established a novel transgenic rat line carrying human microtubule-associated protein Tau-40 with mutation P301L. hTau-40/P301L transgenic male and female rats were followed up to 2 years of age. The hTau-40/P301L rats expressed human tau mRNA and protein in the limbic cortex and associated white matter, hippocampus and spinal cord. With increasing age, the staining density for phosphorylated tau increased in all these areas. Neither silver stains nor Fluoro-Jade staining indicated the presence of dying neurons, or axonal degeneration, and there was no evidence of increased gliosis or inflammation. However, some neurons did display dendritic abnormalities, and immunoblots revealed the presence of sarcosyl insoluble tau. A large test battery revealed no behavioral abnormalities in these rats, except a mild hyperactivity in the elevated plus maze. In conclusion, this transgenic tau rat may be a useful model for ‘pretangle’ pathology, although in this study conditions were not sufficient to induce significant neuronal loss or behavioral deficits.

a Institute of Clinical Medicine, Neurology, University of Kuopio, 70211 Kuopio, Finland

b Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0006, USA

c Department of Biosciences, Biochemistry, University of Kuopio, 70211 Kuopio, Finland

d A. I. Virtanen Institute for Molecular Sciences, Department of Neurobiology, University of Kuopio, 70211 Kuopio, Finland

e Max-Planck-Unit for Structural Molecular Biology, 22607 Hamburg, Germany

f Department of Neurology, Kuopio University Hospital, 70211 Kuopio, Finland

Corresponding Author InformationCorresponding author at: Institute of Clinical Medicine, Neurology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. Tel.: +358 50 361 1470; fax: +358 17 162048.

PII: S0197-4580(10)00007-2

doi:10.1016/j.neurobiolaging.2009.12.022